tiprankstipranks
Trending News
More News >
Aurobindo Pharma Ltd (IN:AUROPHARMA)
:AUROPHARMA
India Market
Advertisement

Aurobindo Pharma Ltd (AUROPHARMA) Ratios

Compare
0 Followers

Aurobindo Pharma Ltd Ratios

IN:AUROPHARMA's free cash flow for Q4 2025 was ₹0.59. For the 2025 fiscal year, IN:AUROPHARMA's free cash flow was decreased by ₹ and operating cash flow was ₹0.16. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 22Dec 22
Liquidity Ratios
Current Ratio
1.85 1.98 1.87 1.87 2.22
Quick Ratio
1.13 1.18 1.13 1.13 1.30
Cash Ratio
0.56 0.28 0.38 0.38 0.51
Solvency Ratio
0.30 0.31 0.24 0.24 0.40
Operating Cash Flow Ratio
0.00 0.20 0.21 0.21 0.62
Short-Term Operating Cash Flow Coverage
0.00 0.58 0.56 0.56 1.97
Net Current Asset Value
₹ 100.24B₹ 89.85B₹ 85.08B₹ 85.08B₹ 87.75B
Leverage Ratios
Debt-to-Assets Ratio
0.17 0.15 0.13 0.13 0.10
Debt-to-Equity Ratio
0.25 0.22 0.20 0.20 0.13
Debt-to-Capital Ratio
0.20 0.18 0.16 0.16 0.12
Long-Term Debt-to-Capital Ratio
0.05 0.07 0.02 0.02 0.01
Financial Leverage Ratio
1.52 1.51 1.49 1.49 1.38
Debt Service Coverage Ratio
0.80 1.11 0.76 0.76 1.49
Interest Coverage Ratio
16.18 36.07 18.16 18.16 89.75
Debt to Market Cap
0.12 0.10 0.16 0.16 0.07
Interest Debt Per Share
150.18 118.41 92.62 92.62 56.59
Net Debt to EBITDA
<0.01 0.53 0.22 0.22 -0.19
Profitability Margins
Gross Profit Margin
58.63%55.22%54.12%54.12%56.60%
EBIT Margin
17.22%16.03%11.14%11.14%14.59%
EBITDA Margin
22.36%21.30%16.29%16.29%19.60%
Operating Profit Margin
23.50%36.03%10.36%10.36%14.15%
Pretax Profit Margin
16.09%15.10%10.61%10.61%14.43%
Net Profit Margin
11.07%10.94%7.83%7.83%11.33%
Continuous Operations Profit Margin
11.06%10.93%7.88%7.88%11.46%
Net Income Per EBT
68.81%72.44%73.78%73.78%78.52%
EBT Per EBIT
68.46%41.91%102.39%102.39%102.01%
Return on Assets (ROA)
7.00%7.04%4.83%4.83%7.81%
Return on Equity (ROE)
11.22%10.63%7.18%7.18%10.78%
Return on Capital Employed (ROCE)
21.08%31.79%8.99%8.99%12.83%
Return on Invested Capital (ROIC)
12.24%20.36%5.75%5.75%9.11%
Return on Tangible Assets
7.65%7.74%5.36%5.36%8.74%
Earnings Yield
5.37%4.86%6.35%6.35%6.76%
Efficiency Ratios
Receivables Turnover
5.48 6.02 5.51 5.51 5.82
Payables Turnover
3.11 2.92 2.92 2.92 3.75
Inventory Turnover
1.24 1.32 1.33 1.33 1.34
Fixed Asset Turnover
2.04 2.01 1.97 1.97 2.19
Asset Turnover
0.63 0.64 0.62 0.62 0.69
Working Capital Turnover Ratio
5.05 2.63 2.46 2.46 2.44
Cash Conversion Cycle
244.67 211.11 216.19 216.19 237.28
Days of Sales Outstanding
66.60 60.62 66.22 66.22 62.67
Days of Inventory Outstanding
295.44 275.69 275.08 275.08 271.90
Days of Payables Outstanding
117.37 125.20 125.12 125.12 97.30
Operating Cycle
362.04 336.31 341.31 341.31 334.58
Cash Flow Ratios
Operating Cash Flow Per Share
0.00 41.56 40.73 40.73 85.61
Free Cash Flow Per Share
0.00 -19.24 -5.69 -5.69 39.46
CapEx Per Share
0.00 60.79 46.43 46.43 46.16
Free Cash Flow to Operating Cash Flow
0.00 -0.46 -0.14 -0.14 0.46
Dividend Paid and CapEx Coverage Ratio
0.00 0.64 0.76 0.76 1.69
Capital Expenditure Coverage Ratio
0.00 0.68 0.88 0.88 1.85
Operating Cash Flow Coverage Ratio
0.00 0.37 0.45 0.45 1.53
Operating Cash Flow to Sales Ratio
0.00 0.08 0.10 0.10 0.21
Free Cash Flow Yield
0.00%-1.73%-1.10%-1.10%5.90%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
18.61 20.56 15.75 15.75 14.79
Price-to-Sales (P/S) Ratio
2.06 2.25 1.23 1.23 1.68
Price-to-Book (P/B) Ratio
1.99 2.19 1.13 1.13 1.59
Price-to-Free Cash Flow (P/FCF) Ratio
0.00 -57.88 -90.99 -90.99 16.94
Price-to-Operating Cash Flow Ratio
0.00 26.79 12.72 12.72 7.81
Price-to-Earnings Growth (PEG) Ratio
222.45 0.32 -0.58 -0.58 -0.29
Price-to-Fair Value
1.99 2.19 1.13 1.13 1.59
Enterprise Value Multiple
9.22 11.08 7.79 7.79 8.36
Enterprise Value
649.26B 684.80B 312.47B 312.47B 382.89B
EV to EBITDA
9.22 11.08 7.79 7.79 8.36
EV to Sales
2.06 2.36 1.27 1.27 1.64
EV to Free Cash Flow
0.00 -60.76 -93.65 -93.65 16.56
EV to Operating Cash Flow
0.00 28.13 13.09 13.09 7.63
Tangible Book Value Per Share
489.26 439.94 391.34 391.34 357.73
Shareholders’ Equity Per Share
562.37 509.39 458.07 458.07 419.43
Tax and Other Ratios
Effective Tax Rate
0.31 0.28 0.26 0.26 0.22
Revenue Per Share
542.31 495.04 420.13 420.13 398.79
Net Income Per Share
60.04 54.16 32.90 32.90 45.20
Tax Burden
0.69 0.72 0.74 0.74 0.79
Interest Burden
0.93 0.94 0.95 0.95 0.99
Research & Development to Revenue
0.00 0.05 <0.01 <0.01 <0.01
SG&A to Revenue
0.00 0.03 0.03 0.03 0.03
Stock-Based Compensation to Revenue
0.00 <0.01 >-0.01 >-0.01 0.00
Income Quality
0.00 0.77 0.91 0.91 1.49
Currency in INR
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis